ID   IP3KC_HUMAN             Reviewed;         683 AA.
AC   Q96DU7; Q9UE25; Q9Y475;
DT   02-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   10-MAY-2017, entry version 120.
DE   RecName: Full=Inositol-trisphosphate 3-kinase C;
DE            EC=2.7.1.127;
DE   AltName: Full=Inositol 1,4,5-trisphosphate 3-kinase C;
DE            Short=IP3 3-kinase C;
DE            Short=IP3K C;
DE            Short=InsP 3-kinase C;
GN   Name=ITPKC; Synonyms=IP3KC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], ENZYME REGULATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Thyroid;
RX   PubMed=11085927; DOI=10.1042/bj3520343;
RA   Dewaste V., Pouillon V., Moreau C., Shears S., Takazawa K., Erneux C.;
RT   "Cloning and expression of a cDNA encoding human inositol 1,4,5-
RT   trisphosphate 3-kinase C.";
RL   Biochem. J. 352:343-351(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 80-683.
RC   TISSUE=Thyroid;
RA   Takazawa K., Go M., Togashi S., Endo T., Erneux C., Onaya T.;
RL   Submitted (SEP-1994) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 531-667.
RC   TISSUE=Placenta;
RA   Erneux C., Communi D.;
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12747803; DOI=10.1042/BJ20021963;
RA   Dewaste V., Moreau C., De Smedt F., Bex F., De Smedt H., Wuytack F.,
RA   Missiaen L., Erneux C.;
RT   "The three isoenzymes of human inositol-1,4,5-trisphosphate 3-kinase
RT   show specific intracellular localization but comparable Ca2+ responses
RT   on transfection in COS-7 cells.";
RL   Biochem. J. 374:41-49(2003).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-336 AND SER-404, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-127, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 425-683 IN COMPLEX WITH
RP   INOSITOL-1,4,5-TRIPHOSPHATE.
RG   Structural genomics consortium (SGC);
RT   "The crystal structure of the catalytic domain of human inositol
RT   1,4,5-trisphosphate 3-kinase C.";
RL   Submitted (OCT-2005) to the PDB data bank.
RN   [9]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO KAWASAKI DISEASE.
RX   PubMed=18157129; DOI=10.1038/ng.2007.45;
RA   Kornak U., Reynders E., Dimopoulou A., van Reeuwijk J., Fischer B.,
RA   Rajab A., Budde B., Nuernberg P., Foulquier F., Dobyns W.B.,
RA   Quelhas D., Vilarinho L., Leao-Teles E., Greally M., Seemanova E.,
RA   Simandlova M., Salih M., Nanda A., Basel-Vanagaite L., Kayserili H.,
RA   Yuksel-Apak M., Larregue M., Vigneron J., Giurgea S., Lefeber D.,
RA   Urban Z., Gruenewald S., Annaert W., Brunner H.G., van Bokhoven H.,
RA   Wevers R., Morava E., Matthijs G., Van Maldergem L., Mundlos S.;
RT   "Impaired glycosylation and cutis laxa caused by mutations in the
RT   vesicular H+-ATPase subunit ATP6V0A2.";
RL   Nat. Genet. 40:32-34(2008).
CC   -!- FUNCTION: Can phosphorylate inositol 2,4,5-triphosphate to
CC       inositol 2,4,5,6-tetraphosphate. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + 1D-myo-inositol 1,4,5-trisphosphate =
CC       ADP + 1D-myo-inositol 1,3,4,5-tetrakisphosphate.
CC   -!- ENZYME REGULATION: Activated by calcium/calmodulin. Inhibited by
CC       high concentrations of the substrate Ins(1,2,4)P3, and
CC       allosterically activated by the product Ins(1,3,4,5)P4.
CC       {ECO:0000269|PubMed:11085927}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12747803}.
CC       Cytoplasm {ECO:0000269|PubMed:12747803}. Note=Shuttles actively
CC       between nucleus and cytoplasm with both nuclear import and nuclear
CC       export activity.
CC   -!- TISSUE SPECIFICITY: Highly expressed in pancreas, skeletal muscle,
CC       liver, placenta and weakly in kidney and brain.
CC       {ECO:0000269|PubMed:11085927}.
CC   -!- DISEASE: Kawasaki disease (KWD) [MIM:611775]: An acute, self-
CC       limited vasculitis of infants and children characterized by
CC       prolonged fever unresponsive to antibiotics, polymorphous skin
CC       rash, erythema of the oral mucosa, lips, and tongue, erythema of
CC       the palms and soles, bilateral conjunctival injection, and
CC       cervical lymphadenopathy. {ECO:0000269|PubMed:18157129}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the inositol phosphokinase (IPK) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ290975; CAC40815.1; -; mRNA.
DR   EMBL; BC060788; AAH60788.1; -; mRNA.
DR   EMBL; D38169; BAA22524.1; -; mRNA.
DR   EMBL; Y11999; CAA72728.1; -; mRNA.
DR   CCDS; CCDS12563.1; -.
DR   RefSeq; NP_079470.1; NM_025194.2.
DR   UniGene; Hs.515415; -.
DR   PDB; 2A98; X-ray; 2.60 A; A=425-683.
DR   PDBsum; 2A98; -.
DR   ProteinModelPortal; Q96DU7; -.
DR   SMR; Q96DU7; -.
DR   BioGrid; 123209; 4.
DR   IntAct; Q96DU7; 1.
DR   STRING; 9606.ENSP00000263370; -.
DR   iPTMnet; Q96DU7; -.
DR   PhosphoSitePlus; Q96DU7; -.
DR   BioMuta; ITPKC; -.
DR   EPD; Q96DU7; -.
DR   MaxQB; Q96DU7; -.
DR   PaxDb; Q96DU7; -.
DR   PeptideAtlas; Q96DU7; -.
DR   PRIDE; Q96DU7; -.
DR   Ensembl; ENST00000263370; ENSP00000263370; ENSG00000086544.
DR   GeneID; 80271; -.
DR   KEGG; hsa:80271; -.
DR   UCSC; uc002oot.5; human.
DR   CTD; 80271; -.
DR   DisGeNET; 80271; -.
DR   GeneCards; ITPKC; -.
DR   HGNC; HGNC:14897; ITPKC.
DR   HPA; HPA050760; -.
DR   HPA; HPA053003; -.
DR   MalaCards; ITPKC; -.
DR   MIM; 606476; gene.
DR   MIM; 611775; phenotype.
DR   neXtProt; NX_Q96DU7; -.
DR   OpenTargets; ENSG00000086544; -.
DR   PharmGKB; PA29977; -.
DR   eggNOG; KOG1621; Eukaryota.
DR   eggNOG; ENOG410Y8AC; LUCA.
DR   GeneTree; ENSGT00390000017438; -.
DR   HOGENOM; HOG000113089; -.
DR   HOVERGEN; HBG081804; -.
DR   InParanoid; Q96DU7; -.
DR   KO; K00911; -.
DR   OMA; SWKELYT; -.
DR   OrthoDB; EOG091G03J3; -.
DR   PhylomeDB; Q96DU7; -.
DR   TreeFam; TF318394; -.
DR   BioCyc; MetaCyc:HS01533-MONOMER; -.
DR   Reactome; R-HSA-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   ChiTaRS; ITPKC; human.
DR   EvolutionaryTrace; Q96DU7; -.
DR   GenomeRNAi; 80271; -.
DR   PRO; PR:Q96DU7; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000086544; -.
DR   CleanEx; HS_ITPKC; -.
DR   ExpressionAtlas; Q96DU7; baseline and differential.
DR   Genevisible; Q96DU7; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0008440; F:inositol-1,4,5-trisphosphate 3-kinase activity; TAS:Reactome.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   InterPro; IPR005522; IPK.
DR   PANTHER; PTHR12400; PTHR12400; 1.
DR   Pfam; PF03770; IPK; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Calmodulin-binding; Complete proteome;
KW   Cytoplasm; Kinase; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transferase.
FT   CHAIN         1    683       Inositol-trisphosphate 3-kinase C.
FT                                /FTId=PRO_0000234070.
FT   NP_BIND     471    473       ATP. {ECO:0000250}.
FT   REGION      507    513       Substrate binding.
FT   REGION      509    517       Calmodulin-binding. {ECO:0000250}.
FT   REGION      534    541       Substrate binding.
FT   MOTIF       324    332       Nuclear export signal. {ECO:0000250}.
FT   BINDING     431    431       ATP. {ECO:0000250}.
FT   BINDING     484    484       ATP. {ECO:0000250}.
FT   BINDING     486    486       Substrate.
FT   BINDING     558    558       ATP. {ECO:0000250}.
FT   BINDING     638    638       ATP. {ECO:0000250}.
FT   BINDING     641    641       Substrate.
FT   MOD_RES     127    127       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     162    162       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q7TS72}.
FT   MOD_RES     336    336       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     404    404       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CONFLICT     80     82       PGT -> NSA (in Ref. 3; BAA22524).
FT                                {ECO:0000305}.
FT   STRAND      427    432       {ECO:0000244|PDB:2A98}.
FT   HELIX       435    444       {ECO:0000244|PDB:2A98}.
FT   HELIX       450    452       {ECO:0000244|PDB:2A98}.
FT   STRAND      456    462       {ECO:0000244|PDB:2A98}.
FT   STRAND      465    471       {ECO:0000244|PDB:2A98}.
FT   TURN        473    476       {ECO:0000244|PDB:2A98}.
FT   STRAND      481    489       {ECO:0000244|PDB:2A98}.
FT   HELIX       494    496       {ECO:0000244|PDB:2A98}.
FT   TURN        500    502       {ECO:0000244|PDB:2A98}.
FT   HELIX       508    515       {ECO:0000244|PDB:2A98}.
FT   HELIX       524    529       {ECO:0000244|PDB:2A98}.
FT   HELIX       534    544       {ECO:0000244|PDB:2A98}.
FT   HELIX       547    550       {ECO:0000244|PDB:2A98}.
FT   STRAND      551    558       {ECO:0000244|PDB:2A98}.
FT   HELIX       574    585       {ECO:0000244|PDB:2A98}.
FT   HELIX       589    608       {ECO:0000244|PDB:2A98}.
FT   HELIX       610    613       {ECO:0000244|PDB:2A98}.
FT   STRAND      615    617       {ECO:0000244|PDB:2A98}.
FT   STRAND      621    626       {ECO:0000244|PDB:2A98}.
FT   STRAND      632    637       {ECO:0000244|PDB:2A98}.
FT   STRAND      642    644       {ECO:0000244|PDB:2A98}.
FT   STRAND      653    655       {ECO:0000244|PDB:2A98}.
FT   TURN        659    661       {ECO:0000244|PDB:2A98}.
FT   HELIX       666    681       {ECO:0000244|PDB:2A98}.
SQ   SEQUENCE   683 AA;  75207 MW;  58093A2A8E046458 CRC64;
     MRRCPCRGSL NEAEAGALPA AARMGLEAPR GGRRRQPGQQ RPGPGAGAPA GRPEGGGPWA
     RTEGSSLHSE PERAGLGPAP GTESPQAEFW TDGQTEPAAA GLGVETERPK QKTEPDRSSL
     RTHLEWSWSE LETTCLWTET GTDGLWTDPH RSDLQFQPEE ASPWTQPGVH GPWTELETHG
     SQTQPERVKS WADNLWTHQN SSSLQTHPEG ACPSKEPSAD GSWKELYTDG SRTQQDIEGP
     WTEPYTDGSQ KKQDTEAARK QPGTGGFQIQ QDTDGSWTQP STDGSQTAPG TDCLLGEPED
     GPLEEPEPGE LLTHLYSHLK CSPLCPVPRL IITPETPEPE AQPVGPPSRV EGGSGGFSSA
     SSFDESEDDV VAGGGGASDP EDRSGSKPWK KLKTVLKYSP FVVSFRKHYP WVQLSGHAGN
     FQAGEDGRIL KRFCQCEQRS LEQLMKDPLR PFVPAYYGMV LQDGQTFNQM EDLLADFEGP
     SIMDCKMGSR TYLEEELVKA RERPRPRKDM YEKMVAVDPG APTPEEHAQG AVTKPRYMQW
     RETMSSTSTL GFRIEGIKKA DGTCNTNFKK TQALEQVTKV LEDFVDGDHV ILQKYVACLE
     ELREALEISP FFKTHEVVGS SLLFVHDHTG LAKVWMIDFG KTVALPDHQT LSHRLPWAEG
     NREDGYLWGL DNMICLLQGL AQS
//
